#competitiveintelligence
LightNews LightNews
drtimos.bsky.social
Signal or noise? > Drug developer Biogen unveils VC investment arm - - Global
Corporate Venturing >> Comment below! #strategy #competitiveintelligence #marketing #pharma #biotech #competitivemarketing #pharmaceutical #healthcare
Drug developer Biogen unveils VC investment arm - - Global Corporate Venturing
Drug developer Biogen unveils VC investment arm -  Global Corporate Venturing
dlvr.it
November 6, 2025 at 9:29 PM
drtimos.bsky.social
Signal or noise? > Forbion Appoints Joy Faucher as General Partner to Support
Continued Growth in Its BioEconomy Strategy - GlobeNewswire >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #healthcare #competitivemarketing
Forbion Appoints Joy Faucher as General Partner to Support Continued Growth in Its BioEconomy Strategy - GlobeNewswire
Forbion Appoints Joy Faucher as General Partner to Support Continued Growth in Its BioEconomy Strategy  GlobeNewswire
dlvr.it
November 3, 2025 at 3:59 PM
drtimos.bsky.social
Signal or noise? > Taysha Gene Therapies Regains Full Global Rights to Lead
Rett Syndrome Program TSHA-102 - Insider Monkey >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #pharma #biotech #healthcare
Taysha Gene Therapies Regains Full Global Rights to Lead Rett Syndrome Program TSHA-102 - Insider Monkey
Taysha Gene Therapies Regains Full Global Rights to Lead Rett Syndrome Program TSHA-102  Insider Monkey
dlvr.it
October 26, 2025 at 3:29 PM
drtimos.bsky.social
Signal or noise? > FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy
Application Reestablishes Momentum For Stock - Benzinga >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #pharmaceutical #healthcare #pharma
FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock - Benzinga
FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock  Benzinga
dlvr.it
October 14, 2025 at 8:59 PM
drtimos.bsky.social
Signal or noise? > Q&A: Scientists behind Baby KJ’s custom CRISPR drug
are planning to help more children  >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #pharma #productmarketing
Q&A: Scientists behind Baby KJ’s custom CRISPR drug are planning to help more children 
SEVILLE, SPAIN — Earlier this year, the long-held dream of personalized gene editing was made real with the creation of a base editing therapy to correct the unique mutation that caused “Baby KJ’s” rare and otherwise ...
dlvr.it
October 9, 2025 at 2:37 AM
drtimos.bsky.social
Signal or noise? > JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to
Central Nervous System and Muscle with Novel Capsid Engineering
Platform Technology -… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #competitivemarketing #biotech
JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology - Yahoo
JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology  Yahoo
dlvr.it
October 7, 2025 at 5:31 PM
drtimos.bsky.social
Thoughts on this? >> Avirmax Biopharma Initiates IND-enabling Studies of ABI-201;
a Breakthrough Gene Therapy for Dry Age-related Macular
Degeneration - BioSpace:… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #pharma #biotech #competitivemarketing
Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration - BioSpace
Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration  BioSpace
dlvr.it
March 3, 2025 at 8:01 AM
drtimos.bsky.social
Thoughts on this? >> Behind the Headlines Episode 12–Cell and Gene Therapies, New
Genomics Tools, and Recent Partnerships - Pharmaceutical Technology
Magazine: Behind… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #competitivemarketing
Behind the Headlines Episode 12–Cell and Gene Therapies, New Genomics Tools, and Recent Partnerships - Pharmaceutical Technology Magazine
Behind the Headlines Episode 12–Cell and Gene Therapies, New Genomics Tools, and Recent Partnerships  Pharmaceutical Technology Magazine
dlvr.it
March 5, 2025 at 5:31 PM
drtimos.bsky.social
Thoughts on this? >> Gene Therapy Market Huge Growth in Future Scope 2024-2031 |
- openPR: Gene Therapy Market Huge Growth in Future Scope 2024-2031 |  openPR >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #competitivemarketing #healthcare
Gene Therapy Market Huge Growth in Future Scope 2024-2031 | - openPR
Gene Therapy Market Huge Growth in Future Scope 2024-2031 |  openPR
dlvr.it
December 17, 2024 at 12:30 PM
drtimos.bsky.social
Thoughts on this? >> Can a new gene therapy reverse heart failure? - Futurity:
Research News: Can a new gene therapy reverse heart failure?  Futurity: Research News >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #pharmaceutical #pharma #biotech
Can a new gene therapy reverse heart failure? - Futurity: Research News
Can a new gene therapy reverse heart failure?  Futurity: Research News
dlvr.it
December 17, 2024 at 1:00 AM
drtimos.bsky.social
Thoughts on this? >> Atsena Therapeutics Announces Dosing Completed in Part A of
Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 to Treat
X-linked… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #healthcare #pharma #pharmaceutical
Atsena Therapeutics Announces Dosing Completed in Part A of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 to Treat X-linked Retinoschisis - The Manila Times
Atsena Therapeutics Announces Dosing Completed in Part A of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 to Treat X-linked Retinoschisis  The Manila Times
dlvr.it
December 16, 2024 at 5:01 PM
drtimos.bsky.social
Thoughts on this? >> How Edinburgh pioneer behind 'holy grail' gene therapy
technology raised £3 million - The Scotsman: How Edinburgh pioneer behind 'holy grail' gene… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #competitivemarketing #biotech
How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million - The Scotsman
How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million  The Scotsman
dlvr.it
December 16, 2024 at 9:00 AM
drtimos.bsky.social
Thoughts on this? >> EyePoint shares more mid-stage data for therapy trying to
compete with Regeneron's Eylea: EyePoint Pharmaceuticals, a biotech attempting to grab a… >> Comment below! #strategy #competitiveintelligence #marketing #productmarketing #pharma #healthcare #biotech #pharmaceutical
EyePoint shares more mid-stage data for therapy trying to compete with Regeneron's Eylea
EyePoint Pharmaceuticals, a biotech attempting to grab a sliver of Regeneron's share of the degenerative eye disease market, said six-month results show its drug met the primary endpoint in a Phase 2 trial. At first ...
dlvr.it
February 5, 2025 at 5:30 PM
drtimos.bsky.social
Thoughts on this? >> Gene Therapy Market Trends in Market Growth: Size, Demand, -
openPR: Gene Therapy Market Trends in Market Growth: Size, Demand,  openPR >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #competitivemarketing #healthcare
Gene Therapy Market Trends in Market Growth: Size, Demand, - openPR
Gene Therapy Market Trends in Market Growth: Size, Demand,  openPR
dlvr.it
December 4, 2024 at 12:02 PM
drtimos.bsky.social
Thoughts on this? >> FDA Investigates Reports of Blood Cancer Cases Linked to
Gene Therapy - geneonline: FDA Investigates Reports of Blood Cancer Cases Linked to Gene… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #competitivemarketing #biotech #pharmaceutical
FDA Investigates Reports of Blood Cancer Cases Linked to Gene Therapy - geneonline
FDA Investigates Reports of Blood Cancer Cases Linked to Gene Therapy  geneonline
dlvr.it
December 3, 2024 at 11:14 AM
drtimos.bsky.social
Thoughts on this? >> CGT opening-up to spur China's bio-medical industry - China
Daily: CGT opening-up to spur China's bio-medical industry  China Daily >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #biotech #healthcare #pharma
CGT opening-up to spur China's bio-medical industry - China Daily
CGT opening-up to spur China's bio-medical industry  China Daily
dlvr.it
November 28, 2024 at 4:00 AM
drtimos.bsky.social
Thoughts on this? >> Andelyn Biosciences Expands AAV Curator Platform Offering -
Contract Pharma: Andelyn Biosciences Expands AAV Curator Platform Offering  Contract… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #biotech #pharmaceutical #pharma
Andelyn Biosciences Expands AAV Curator Platform Offering - Contract Pharma
Andelyn Biosciences Expands AAV Curator Platform Offering  Contract Pharma
dlvr.it
February 22, 2025 at 4:00 AM
drtimos.bsky.social
Thoughts on this? >> Eikon raises $351M Series D, pipeline advances to Phase
3: One of biotech's best-funded startups has just raised a huge new round to take its lead drug… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #biotech #productmarketing #pharmaceutical
Eikon raises $351M Series D, pipeline advances to Phase 3
One of biotech's best-funded startups has just raised a huge new round to take its lead drug into final-stage testing. On Wednesday, Eikon Therapeutics announced a $351 million Series D round, one of the biggest ...
dlvr.it
February 26, 2025 at 12:49 PM
drtimos.bsky.social
Thoughts on this? >> FDA advances Precigen's gene therapy for respiratory disease
By Investing.com - Investing.com South Africa: FDA advances Precigen's gene therapy… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #healthcare #biotech
FDA advances Precigen's gene therapy for respiratory disease By Investing.com - Investing.com South Africa
FDA advances Precigen's gene therapy for respiratory disease By Investing.com  Investing.com South Africa
dlvr.it
February 25, 2025 at 3:01 PM
drtimos.bsky.social
Thoughts on this? >> Regeneron, two Chinese biotechs tout promise of their
hearing loss gene therapies - Endpoints News: Regeneron, two Chinese biotechs tout promise of… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #healthcare #pharmaceutical #pharma
Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapies - Endpoints News
Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapies  Endpoints News
dlvr.it
February 26, 2025 at 5:31 PM
drtimos.bsky.social
Thoughts on this? >> VC firm Kineticos launches biotech to develop fresh approach
to antibiotic resistance: Venture capital firm Kineticos Life Sciences has launched a… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #competitivemarketing #healthcare
VC firm Kineticos launches biotech to develop fresh approach to antibiotic resistance
Venture capital firm Kineticos Life Sciences has launched a new biotech to take forward a class of antibiotics forged in the labs of Harvard University.
dlvr.it
February 24, 2025 at 12:31 PM
drtimos.bsky.social
Thoughts on this? >> Doctors in London cure blindness in children with rare
condition - The Guardian: Doctors in London cure blindness in children with rare condition… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #pharma #biotech #pharmaceutical
Doctors in London cure blindness in children with rare condition - The Guardian
Doctors in London cure blindness in children with rare condition  The Guardian
dlvr.it
February 21, 2025 at 9:00 AM
drtimos.bsky.social
Thoughts on this? >> Private equity firms rescue bluebird bio out of its misery -
The Pharma Letter: Private equity firms rescue bluebird bio out of its misery  The… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #healthcare #pharmaceutical #pharma
Private equity firms rescue bluebird bio out of its misery - The Pharma Letter
Private equity firms rescue bluebird bio out of its misery  The Pharma Letter
dlvr.it
February 22, 2025 at 3:31 PM
drtimos.bsky.social
Thoughts on this? >> Illinois DHFS issues report on sickle cell gene and cell
therapy treatments - Spectrum News: Illinois DHFS issues report on sickle cell gene and… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #pharmaceutical #healthcare
Illinois DHFS issues report on sickle cell gene and cell therapy treatments - Spectrum News
Illinois DHFS issues report on sickle cell gene and cell therapy treatments  Spectrum News
dlvr.it
January 13, 2025 at 3:00 AM
drtimos.bsky.social
Thoughts on this? >> DEA issues proposed rule to permanently expand online
prescribing of controlled substances: The Drug Enforcement Administration on Wednesday issued a… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #productmarketing #pharma #healthcare
DEA issues proposed rule to permanently expand online prescribing of controlled substances
The Drug Enforcement Administration on Wednesday issued a long-awaited proposed rule that would create a permanent process for clinicians to more easily prescribe controlled drugs online. The proposal would create a ...
dlvr.it
January 15, 2025 at 10:33 PM